Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC 3052, Australia.
Department of Paediatrics, University of Melbourne, Melbourne, VIC 3052, Australia.
Med. 2021 Jan 15;2(1):49-73. doi: 10.1016/j.medj.2020.06.004. Epub 2020 Jul 9.
In about half of all patients with a suspected monogenic disease, genomic investigations fail to identify the diagnosis. A contributing factor is the difficulty with repetitive regions of the genome, such as those generated by segmental duplications. The locus is one such region, in which recessive deletions and dominant duplications have recently been reported to cause lethal perinatal mitochondrial diseases characterized by pontocerebellar hypoplasia or cardiomyopathy, respectively.
Whole exome, whole genome and long-read DNA sequencing techniques combined with studies of RNA and quantitative proteomics were used to investigate 17 subjects from 16 unrelated families with suspected mitochondrial disease.
We report six different duplications in the gene locus causing a distinctive presentation including lethal perinatal cardiomyopathy, persistent hyperlactacidemia, and frequently corneal clouding or cataracts and encephalopathy. The recurrent 68 Kb duplications are identifiable from genome and exome sequencing but usually missed by microarrays. The duplications result in the formation of identical chimeric ATAD3A/ATAD3C proteins, altered ATAD3 complexes and a striking reduction in mitochondrial oxidative phosphorylation complex I and its activity in heart tissue.
duplications appear to act in a dominant-negative manner and the inheritance infers a low recurrence risk for families, unlike most pediatric mitochondrial diseases. More than 350 genes underlie mitochondrial diseases. In our experience the locus is now one of the five most common causes of nuclear-encoded pediatric mitochondrial disease but the repetitive nature of the locus means diagnoses may be frequently missed by current genomic strategies.
Australian NHMRC, US Department of Defense, Japanese AMED and JSPS agencies, Australian Genomics Health Alliance and Australian Mito Foundation.
在大约一半有疑似单基因疾病的患者中,基因组研究未能确定诊断。一个促成因素是基因组中重复区域的困难,例如那些由片段重复产生的区域。 基因座就是这样一个区域,最近有报道称,隐性缺失和显性重复分别导致致死性围产期线粒体疾病,其特征分别为桥脑小脑发育不良或心肌病。
使用全外显子组、全基因组和长读 DNA 测序技术,并结合 RNA 和定量蛋白质组学研究,对 16 个无关家族的 17 名疑似线粒体疾病患者进行了研究。
我们报告了 6 种不同的 基因座内的重复,导致了一种独特的表现,包括致死性围产期心肌病、持续性高乳酸血症,以及经常出现角膜混浊或白内障和脑病。可从基因组和外显子组测序中识别出反复出现的 68 Kb 重复,但通常会被微阵列错过。这些重复导致形成相同的嵌合 ATAD3A/ATAD3C 蛋白,改变的 ATAD3 复合物,以及在心脏组织中线粒体氧化磷酸化复合物 I 及其活性的明显减少。
重复似乎以显性负性方式起作用,并且遗传推断出家族的复发风险较低,这与大多数儿科线粒体疾病不同。超过 350 个基因是线粒体疾病的基础。根据我们的经验, 基因座现在是导致核编码儿科线粒体疾病的五个最常见原因之一,但该基因座的重复性质意味着目前的基因组策略可能经常错过诊断。
澳大利亚 NHMRC、美国国防部、日本 AMED 和 JSPS 机构、澳大利亚基因组健康联盟和澳大利亚线粒体基金会。